Background: Non-compacted myocardium is a recently described cardiomyopathy. It can present itself at any age as different clinical entities, such as heart failure syndrome, arrhythmias, systemic embolism, or sudden death. Scientifi c evidence demonstrates a decrease in mortality in patients with heart failure who are admitted to cardiac rehabilitation programs. Objective: To evaluate the effect of phase II cardiac rehabilitation programs in patients diagnosed with heart failure secondary to non-compacted myocardium. Material and methods: An observational and retrospective study was performed, reviewing the cases diagnosed with non-compacted myocardium registered in the Cardiac Rehabilitation Service until 2016. Results: Five patients with a mean age of 42 ± 10.5 years were included, with a female majority. At the end of the phase II cardiac rehabilitation program, all the patients presented decreased dyspnea, edema and plethora (100%, p = 0.063); a reduction in systolic blood pressure, mean: 4.8 mmHg, p = 0.434; an increase of maximum heart rate, average of 10 beats per minute, p = 0.178. No changes were observed in the Mets or in the stress test time. Conclusions: Cardiac rehabilitation represents an alternative in the management of heart failure secondary to non-compacted myocardium.
Read full abstract